Plastic Surgery Doctors in Akron, OH Accepting Medicare

8 Plastic Surgery doctors found. Showing 1 - 8

Dr. Michael George Parker, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Park West Blvd, Suite 350, Akron, OH 44320 Phone: 330-253-9161    Fax: 330-253-5933

Dr. James A Lehman Jr., M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 300 Locust St, Suite 590, Akron, OH 44302 Phone: 330-374-9100    Fax: 330-374-9103

Ananth S Murthy, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-4970    Fax: 330-543-4971

Dr. Douglas Scott Wagner, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3925 Embassy Pkwy Ste 300, Akron, OH 44333 Phone: 330-668-4065    Fax: 330-668-4082

A. Lawrence Cervino, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3925 Embassy Pkwy, #300, Akron, OH 44333 Phone: 330-668-4065    Fax: 330-668-4082

Daniel James Ransel Yoho, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3925 Embassy Pkwy, Akron, OH 44333 Phone: 330-673-6299

Niyant V. Patel, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-4970    Fax: 330-543-4971

Haiqiao Jiao, MD Plastic Surgery - Surgery of the Hand Medicare: Accepting Medicare Assignments Practice Location: 3925 Embassy Pkwy Ste 200, Akron, OH 44333 Phone: 330-668-4055    Fax: 330-668-4077

News Archive

Republican rivals' attacks on 'Romneycare' gaining traction

GOP presidential hopeful Mitt Romney's health policies are not only the target of his Republican opponents but are also drawing attention and barbs from Democrats. Also on the trail, Newt Gingrich, another GOP primary candidate, criticized the tenor of the campaign season so far.

Adjunctive lacosamide reduces seizures and improves responder rates

Comprehensive analyses of pooled data from three randomized, double-blind, placebo-controlled Phase II/III trials showing the efficacy and tolerability of Vimpat® (lacosamide) C-V for patients with partial-onset seizures, regardless of the type of concomitant AED used, have been published in the drug evaluation journal, CNS Drugs.

Almac reports substantial progress in transitioning operations to new headquarters

Almac is making substantial progress in transitioning operations to its new headquarters in Souderton, PA, especially in the area of distribution. The new facility has been successfully shipping clinical trial materials since November, and has recently seen an increase in shipment volumes due to the added efficiencies the new building provides.

Genentech's Lucentis for treatment of macular edema following RVO receives FDA approval

Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has approved Lucentis® (ranibizumab injection) for the treatment of macular edema following retinal vein occlusion (RVO). The FDA approved this new indication after a six-month Priority Review.

Expedited partner therapy for STIs provides health and cost benefits

In some states, patients who test positive for chlamydia or gonorrhea leave the clinic with not only a prescription for themselves, but also one for their sexual partner - who was not seen by a doctor.

Read more Medical News

› Verified 6 days ago